Protagonist Therapeutics
PTGX
PTGX
188 hedge funds and large institutions have $2.05B invested in Protagonist Therapeutics in 2024 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 63 increasing their positions, 68 reducing their positions, and 26 closing their positions.
Holders
188
Holders Change
+3
Holders Change %
+1.62%
% of All Funds
2.73%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.12%
New
30
Increased
63
Reduced
68
Closed
26
Calls
$956K
Puts
$7.56M
Net Calls
-$6.61M
Net Calls Change
-$894K
Top Buyers
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$12M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$72.2M |
| 3 |
BI
3
BVF Inc
San Francisco,
California
|
$115M |
| 4 |
4
Marshall Wace
London,
United Kingdom
|
$19.8M |
| 5 |
CAC
5
Cowen and Company
New York
|
$41M |
